Related Experiment Video
Updated: Jul 3, 2026

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
Slit-2 induces a tumor-suppressive effect by regulating beta-catenin in breast cancer cells
Anil Prasad1, Vikram Paruchuri, Anju Preet
1Division of Experimental Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02115, USA. abailugu@bidmc.harvard.edu
Abstract:
SLIT-2 is considered as a candidate tumor suppressor gene, because it is frequently inactivated in various cancers due to hypermethylation of its promoter region and allelic loss. However, the exact mechanism of its tumor-suppressive effect has not been elucidated. Here, we observed that Slit-2-overexpressing breast cancer cells exhibited decreased proliferation and migration capabilities compared with control cells under in vitro conditions. These results were confirmed in vivo in mouse model systems. Mice injected with MCF-7/Slit-2 cells showed a 60-70% reduction in tumor size compared with mice injected with MCF-7/VC cells both in the absence and presence of estrogen. Upon further elucidation, we observed that Slit-2 mediates the tumor-suppressive effect via a coordinated regulation of the beta-catenin and PI3K signaling pathways and by enhancing beta-catenin/E-cadherin-mediated cell-cell adhesion. Our study for the first time reveals that Slit-2-overexpressing breast cancer cells exhibit tumor suppressor capabilities through the novel mechanism of beta-catenin modulation.
Insights
Slit-2 acts as a tumor suppressor in breast cancer by inhibiting cell proliferation and migration. This study reveals Slit-2
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Slit-2 is a potential tumor suppressor gene, frequently inactivated in cancers via promoter hypermethylation and allelic loss.
- The precise mechanism underlying Slit-2's tumor-suppressive function remains unclear.
Purpose of the Study:
- To investigate the tumor-suppressive role of Slit-2 in breast cancer.
- To elucidate the molecular mechanisms by which Slit-2 exerts its effects.
Main Methods:
- In vitro studies using breast cancer cell lines overexpressing Slit-2.
- In vivo experiments using mouse models to assess tumor growth.
- Analysis of beta-catenin and PI3K signaling pathways.
Main Results:
- Slit-2 overexpression reduced breast cancer cell proliferation and migration in vitro.
- Tumor size was significantly reduced (60-70%) in mice injected with Slit-2-overexpressing cells.
- Slit-2 modulated beta-catenin and PI3K pathways, enhancing beta-catenin/E-cadherin cell-cell adhesion.
Conclusions:
- Slit-2 exhibits tumor suppressor capabilities in breast cancer.
- Slit-2 exerts its effects by regulating beta-catenin and PI3K signaling pathways.
- This study identifies beta-catenin modulation as a novel mechanism for Slit-2's tumor suppression.
Related Concept Videos
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Inhibition of Cdk Activity
Canonical Wnt Signaling Pathway